Extracellular Expression and Diagnostic Potential of Dengue Virus Type 3 E Protein Domain III Through Codon Optimization in Komagataella phaffii
- PMID: 40608275
- DOI: 10.1007/s12033-025-01468-8
Extracellular Expression and Diagnostic Potential of Dengue Virus Type 3 E Protein Domain III Through Codon Optimization in Komagataella phaffii
Abstract
Dengue is a mosquito-borne viral disease caused by the dengue virus (DENV), which affects millions worldwide. The envelope (E) protein, particularly domain III (EDIII), plays a critical role in viral entry and is a major target for diagnostic and vaccine development. In this study, we aimed to express and purify EDIII from DENV-3 using Komagataella phaffii as an expression system. The recombinant gene was codonoptimized, cloned into the pPICZαA vector, and integrated into the K. phaffii genome. Protein expression was induced with methanol and purified using Ni2+-affinity chromatography, yielding 209-309 mg/L. SDS-PAGE and Western blot confirmed protein expression. The recombinant antigen was evaluated in an indirect ELISA with 92 serum samples, demonstrating an AUC of 0.94 (IgM) and 0.828 (IgG), with 92% specificity for IgM. These results suggest that K. phaffii is a suitable host for recombinant dengue antigen production, offering a scalable and cost-effective strategy for diagnostic applications.
Keywords: Bioprocess; Codon optimization; DENV; Dengue; Domain III (EDIII); Heterologous expression; Recombinant protein; Yeast.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Development of tobacco chloroplast vector with novel insertion sites for dengue virus (DENV) antigens.Protoplasma. 2025 Jul 17. doi: 10.1007/s00709-025-02087-5. Online ahead of print. Protoplasma. 2025. PMID: 40676266
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Prevalence of dengue in febrile patients in Peru: A systematic review and meta-analysis.PLoS One. 2025 Jun 17;20(6):e0310163. doi: 10.1371/journal.pone.0310163. eCollection 2025. PLoS One. 2025. PMID: 40526741 Free PMC article.
-
A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.J Virol. 2017 Mar 29;91(8):e02388-16. doi: 10.1128/JVI.02388-16. Print 2017 Apr 15. J Virol. 2017. PMID: 28148804 Free PMC article.
References
-
- Jamal, Z., Haider, S. A., Hakim, R., Humayun, F., Farooq, M. U., Ammar, M., Afrough, B., Inamdar, L., Salman, M., & Umair, M. (2024). Serotype and genomic diversity of dengue virus during the 2023 outbreak in Pakistan reveals the circulation of genotype III of DENV-1 and cosmopolitan genotype of DENV-2. Journal of Medical Virology, 96(6), e29727. https://doi.org/10.1002/jmv.29727 - DOI - PubMed
-
- da Silva, I. B. N., de Moraes Rodrigues, J., Batista, R. C. G., Dos Santos Gomes, V., de Souza Chacon, C., da Silva Almeida, M., de Araujo, T. S., Ortiz da Silva, B., Castiñeiras, T. M. P. P., Ferreira Junior, O. D. C., Carneiro, F. A., & Montero-Lomeli, M. (2024). Development and assessment of a multiepitope synthetic antigen for the diagnosis of Dengue virus infection. Brazilian Journal of Infectious Diseases, 28(3), 103746. https://doi.org/10.1016/j.bjid.2024.103746 - DOI
-
- Munt, J. E., Henein, S., Adams, C., Young, E., Hou, Y. J., Conrad, H., Zhu, D., Dong, S., Kose, N., Yount, B., Meganck, R. M., Tse, L. P. V., Kuan, G., Balmaseda, A., Ricciardi, M. J., Watkins, D. I., Crowe, J. E., Harris, E., De Silva, A. M., & Baric, R. S. (2023). Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination. Cell Host and Microbe, 31(11), 1850.e5-1865.e5. https://doi.org/10.1016/j.chom.2023.10.004 - DOI
-
- Zhu, D. R., Rajesh, A. J., Meganck, R. M., Young, E. F., Munt, J. E., Tse, V. L., Yount, B., Conrad, H., White, L., Henein, S., De Silva, A. M., & Baric, R. S. (2023). Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2. MBio, 14(5), e0081823. https://doi.org/10.1128/mbio.00818-23 - DOI - PubMed
-
- Li, Z., Liu, H.-Y., He, Z., Chakravarty, A., Golden, R. P., Jiang, Z., You, I., Yue, H., Donovan, K. A., Du, G., Che, J., Tse, J., Che, I., Lu, W., Fischer, E. S., Zhang, T., Gray, N. S., & Yang, P. L. (2024). Discovery of potent degraders of the Dengue virus envelope protein. bioRxiv, 11(40), e2405829. https://doi.org/10.1101/2024.06.01.596987 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources